- Home
- IVR vs ALT Comparison
IVR vs ALT Comparison
Compare IVR & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVR
- ALT
- Stock Information
- Founded
- IVR 2008
- ALT 1997
- Country
- IVR United States
- ALT United States
- Employees
- IVR N/A
- ALT N/A
- Industry
- IVR Real Estate Investment Trusts
- ALT Biotechnology: Pharmaceutical Preparations
- Sector
- IVR Real Estate
- ALT Health Care
- Exchange
- IVR Nasdaq
- ALT Nasdaq
- Market Cap
- IVR 515.0M
- ALT 457.0M
- IPO Year
- IVR 2009
- ALT N/A
- Fundamental
- Price
- IVR $8.38
- ALT $8.25
- Analyst Decision
- IVR Buy
- ALT Buy
- Analyst Count
- IVR 2
- ALT 7
- Target Price
- IVR N/A
- ALT $20.00
- AVG Volume (30 Days)
- IVR 1.3M
- ALT 3.4M
- Earning Date
- IVR 11-05-2024
- ALT 11-12-2024
- Dividend Yield
- IVR 19.12%
- ALT N/A
- EPS Growth
- IVR N/A
- ALT N/A
- EPS
- IVR 1.23
- ALT N/A
- Revenue
- IVR $102,893,000.00
- ALT $52,000.00
- Revenue This Year
- IVR N/A
- ALT N/A
- Revenue Next Year
- IVR $6.62
- ALT N/A
- P/E Ratio
- IVR $6.81
- ALT N/A
- Revenue Growth
- IVR 654.96
- ALT N/A
- 52 Week Low
- IVR $7.60
- ALT $5.28
- 52 Week High
- IVR $9.97
- ALT $14.84
- Technical
- Relative Strength Index (RSI)
- IVR 49.61
- ALT 48.05
- Support Level
- IVR $8.17
- ALT $7.71
- Resistance Level
- IVR $8.65
- ALT $9.59
- Average True Range (ATR)
- IVR 0.18
- ALT 0.81
- MACD
- IVR -0.01
- ALT -0.17
- Stochastic Oscillator
- IVR 48.19
- ALT 17.17
About IVR INVESCO MORTGAGE CAPITAL INC
Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.
About ALT Altimmune Inc.
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.